Join in-house counsel, colleagues from across the country, and industry leaders to explore the latest developments in drug and medical device litigation. Discover strategies to leverage Federal Rule of Evidence 702 to effectively challenge expert opinions. Gain insights into how drug and medical device litigation is evolving—globally and substantively. Engage directly with in-house counsel on issues that shape their work and relationships with outside counsel. Strengthen your trial advocacy skills with best practices from leading trial lawyers. Examine the ethical use of AI to ensure compliance with Rule 11, client obligations, and fast-evolving court guidelines.
Product liability partner Brian Cadigan will speak on a panel titled, “Beyond Traditional Product Claims: Ethylene Oxide, PFAS, and the Next Wave of ‘Drug & Device Litigation’” on Thursday, May 21, at 2:00 PM EST.
Senior Life Science Policy Analyst Jim Beck will deliver a session titled, “Revenge of the Nerd – A Baker’s Dozen Bright Career Ideas From ‘Bexis’” on Friday, May 22, at 9:40 AM EST.
Brian Cadigan serves on DRI’s Drug and Medical Device Steering Committee, and Jennifer Eppensteiner, Reed Smith counsel, is the Marketing Chair for the 2026 DRI Drug and Medical Device Seminar.
In addition to Brian and Jim's speaking engagements, several Reed Smith attorneys will be in attendance, including partners Steven Boranian, Jesse Ash, Julia Lopez, and Matt Jacobson, along with counsel Jennifer Eppensteiner, Sarah Johansen, and Jamie Lanphear.
